Researchers evaluated the efficacy and safety of ixekizumab over a 16-week period for the treatment of juvenile psoriatic arthritis or enthesitis-related arthritis.
Deucravacitinib was safe and effective for treating moderate to severe scalp psoriasis over 16 weeks, even among patients with less extensive overall disease. Deucravacitinib demonstrates significant ...
The Food and Drug Administration (FDA) has approved Zurnai ™, the first nalmefene HCl autoinjector for the emergency treatment of known or suspected opioid overdose in adults an ...
After peak in 2020, significant decrease seen in firearm injury-related visit rates year over year from 2020 to 2023 ...
The American Academy of Sleep Medicine published guidance regarding the treatment of restless leg syndrome and periodic limb movement disorder.
Researchers assessed the safety and efficacy of apremilast over a 48-week period for the treatment of early oligoarticular psoriatic arthritis.
Seasonal maternal RSV vaccination may be cost-effective, as well as nirsevimab, particularly for those with higher risks.
Viloxazine ER may reduce body weight by decreasing the impulsivity and compulsivity that contributes to overeating. Relative to placebo, Viloxazine extended-release (viloxazine ER) treatment for ...
Respondents who participated in continuing medical education had the highest familiarity with TD therapies. Managing patients with tardive dyskinesia (TD) requires evolving educational needs, with ...
High Medicaid reimbursement rates were associated with 24% lower total health care costs and 23% fewer emergency department visits. Higher Medicaid reimbursement rates for psychiatrists are ...
Fatigue, sleep disturbance, executive function, and working memory losses were seen more often in the younger patients (18-44 years) compared with older patients. HealthDay News — Younger and ...
While rising postpartum depression rates reflect improved screening and diagnosis, the need now shifts to interventions to prevent and treat the condition. HealthDay News — Diagnosis of ...